Oxysterols direct immune cell migration through EBI2
Hannedouche, Sébastien, Zhang, Juan, Yi, Tangsheng, Shen, Weijun, Nguyen, Deborah, Pereira, João P., Guerini, Danilo, Baumgarten, Birgit U., Roggo, Silvio, Wen, Ben, Knochenmuss, Richard, Noël, Sophie, Gessier, Francois, Kelly, Lisa M., Vanek, Mirka, Laurent, Stephane, Preuss, Inga, Miault, Charlotte, Christen, Isabelle, Karuna, Ratna, Li, Wei, Koo, Dong-In, Suply, Thomas, Schmedt, Christian, Peters, Eric C., Falchetto, Rocco, Katopodis, Andreas, Spanka, Carsten, Roy, Marie-Odile, Detheux, Michel, Chen, Yu Alice, Schultz, Peter G., Cho, Charles Y., Seuwen, Klaus, Cyster, Jason G., Sailer, Andreas W.
Published in Nature (London) (27.07.2011)
Published in Nature (London) (27.07.2011)
Get full text
Journal Article
A truncated form of CKbeta8-1 is a potent agonist for human formyl peptide-receptor-like 1 receptor
Elagoz, Aram, Henderson, Duncan, Babu, Poda Suresh, Salter, Sylvia, Grahames, Caroline, Bowers, Lorna, Roy, Marie-Odile, Laplante, Patricia, Grazzini, Eric, Ahmad, Sultan, Lembo, Paola M C
Published in British journal of pharmacology (01.01.2004)
Get full text
Published in British journal of pharmacology (01.01.2004)
Journal Article
A truncated form of CK[beta]8-1 is a potent agonist for human formyl peptide-receptor-like 1 receptor
Elagoz, Aram, Henderson, Duncan, Poda Suresh Babu, Salter, Sylvia, Grahames, Caroline, Bowers, Lorna, Roy, Marie-Odile, Laplante, Patricia, Grazzini, Eric, Sultan, Ahmad, Lembo, Paola M C
Published in British journal of pharmacology (01.01.2004)
Published in British journal of pharmacology (01.01.2004)
Get full text
Journal Article
Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof
Roy, Marie-Odile, El Bousmaqui, Mohamed, Batt, Frederic, Fraser, Graeme Lovat, Hoveyda, Hamid R, Dutheuil, Guillaume
Year of Publication 09.03.2021
Get full text
Year of Publication 09.03.2021
Patent
NOVEL CHIRAL N-ACYL-5,6,7(8-SUBSTITUTED)-TETRAHYDRO-[1,2,4]TRIAZOLO[4,3-A]PYRAZINES AS SELECTIVE NK-3 RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITION, METHODS FOR USE IN NK-3 RECEPTOR MEDIATED DISORDERS AND CHIRAL SYNTHESIS THEREOF
Roy, Marie-Odile, Batt, Frederic, Fraser, Graeme Lovat, Hoveyda, Hamid R, Dutheuil, Guillaume, Bousmaqui, Mohamed El
Year of Publication 10.09.2020
Get full text
Year of Publication 10.09.2020
Patent
Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-A]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof
Roy, Marie-Odile, Batt, Frederic, Fraser, Graeme Lovat, Hoveyda, Hamid R, Dutheuil, Guillaume, Bousmaqui, Mohamed El
Year of Publication 16.06.2020
Get full text
Year of Publication 16.06.2020
Patent
CHIRAL N-ACYL-5,6,7,(8-SUBSTITUTED)-TETRAHYDRO-[1,2,4]TRIAZOLO[4,3-A]PYRAZINES AS SELECTIVE NK-3 RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITION, METHODS FOR USE IN NK-3 RECEPTOR MEDIATED DISORDERS AND CHIRAL SYNTHESIS THEREOF
HOVEYDA, HAMID, ROY, MARIE-ODILE, EL BOUSMAQUI, MOHAMED, DUTHEUIL, GUILLAUME, FRASER, GRAEME, BATT, FREDERIC
Year of Publication 11.06.2019
Get full text
Year of Publication 11.06.2019
Patent